(Q54364026)

English

The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

papillary thyroid cancer

1 reference

based on heuristic

inferred from title

Seyed Rasoul Zakavi

8

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

author name string

Mahdi Daliri

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Mohammad Reza Abbaszadegan

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Mostafa Mehrabi Bahar

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Azadeh Arabi

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Mona Yadollahi

5

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Azar Ghafari

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Negin Taghehchian

7

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

publication date

28 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Endocrine Research

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

39

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

189-193

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

'Aggressive papillary' thyroid microcarcinoma.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Mitogen-activated protein kinases in cell-cycle control

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

BRAF mutations in an Italian cohort of thyroid cancers.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Clinical prognosis in BRAF-mutated PTC.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Prognostic factors in well-differentiated thyroid carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

The prevalence and prognostic value of BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2013.879169

21 January 2018

Identifiers

10.3109/07435800.2013.879169

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/24679337

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54364026&oldid=1506838588"